Export 36 results:
Author Title Type [ Year(Asc)]
Filters: Author is Dawson, Peter  [Clear All Filters]
2022
G. Meyers, Hamadani, M., Martens, M., Ali, H., Choe, H., Dawson, P., Harris, A. C., van Hooren, E., Klaassen, W., Leifer, E., MacMillan, M. L., van Oosterhout, Y., Perez, L., Pusic, I., Vo, P., and Levine, J. E., “Lessons Learned from Early Closure of a Clinical Trial for Steroid-refractory Acute GVHD”, Bone Marrow Transplant, vol. 57, no. 2, pp. 302-303, 2022.
Q. Bashir, Nishihori, T., Pasquini, M. C., Martens, M. J., Wu, J., Alsina, M., Anasetti, C., Brunstein, C., Dawson, P., Efebera, Y., Gasparetto, C., Geller, N., Giralt, S., Hall, A. C., Koreth, J., McCarthy, P., Scott, E., Stadtmauer, E. A., Vesole, D. H., and Hari, P., “A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial”, Transplant Cell Ther, vol. S2666-6367, no. 22, pp. 01467-1, 2022.
2020
L. Wieczorek, Peachman, K., Adams, D. J., Barrows, B., Molnar, S., Schoen, J., Dawson, P., Bryant, C., Chenine, A. - L., Sanders-Buell, E., Srithanaviboonchai, K., Pathipvanich, P., Michael, N. L., Robb, M. L., Tovanabutra, S., Rao, M., and Polonis, V. R., “Evaluation of HIV-1 neutralizing and binding antibodies in maternal-infant transmission in Thailand.”, Virology, vol. 548, pp. 152-159, 2020.
J. Pidala, Hamadani, M., Dawson, P., Martens, M., Alousi, A. M., Jagasia, M., Efebera, Y. A., Chhabra, S., Pusic, I., Holtan, S. G., Ferrara, J. L. M., Levine, J. E., Mielcarek, M., Anasetti, C., Antin, J. H., Bolaños-Meade, J., Howard, A., Logan, B. R., Leifer, E. S., Pritchard, T. S., Horowitz, M. M., and MacMillan, M. L., “Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial.”, Blood, vol. 135, no. 2, pp. 97-107, 2020.
K. E. Stephenson, Tan, C. Sabrina, Walsh, S. R., Hale, A., Ansel, J. L., Kanjilal, D. G., Jaegle, K., Peter, L., Borducchi, E. N., Nkolola, J. P., Makoni, T., Fogel, R., Bradshaw, C., Tyler, A., Moseley, E., Chandrashekar, A., Yanosick, K. E., Seaman, M. S., Eckels, K. H., De La Barrera, R. A., Thompson, J., Dawson, P., Thomas, S. J., Michael, N. L., Modjarrad, K., and Barouch, D. H., “Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial.”, Lancet Infect Dis, vol. 20, no. 9, pp. 1061-1070, 2020.
2019
A. Letizia, Eller, M. A., Polyak, C., Eller, L. Anne, Creegan, M., Dawson, P., Bryant, C., D, K., Crowell, T. A., Lombardi, K., Rono, E., Robb, M. L., Michael, N. L., Maswai, J., and Ake, J. A., “Biomarkers of Inflammation Correlate With Clinical Scoring Indices in Human Immunodeficiency Virus-Infected Kenyans.”, J Infect Dis, vol. 219, no. 2, pp. 284-294, 2019.
L. C. Kottyan, Maddox, A., Braxton, J. R., Stucke, E. M., Mukkada, V., Putnam, P. E., J Abonia, P., Chehade, M., Wood, R. A., Pesek, R. D., Vickery, B. P., Furuta, G. T., Dawson, P., Sampson, H. A., Martin, L. J., Kelly, J. A., Kimberly, R. P., Sivils, K., Gaffney, P. M., Kaufman, K., Harley, J. B., and Rothenberg, M. E., “Genetic variants at the 16p13 locus confer risk for eosinophilic esophagitis.”, Genes Immun, vol. 20, no. 4, pp. 281-292, 2019.
2018
M. - A. Conteh, Goldstein, S. T., Wurie, H. R., Gidudu, J., Lisk, D. Radcliffe, Carter, R. J., Seward, J. F., Hampton, L. M., Wang, D., Andersen, L. E., Arvay, M., Schrag, S. J., Dawson, P., Fombah, A. E., Petrie, C. R., Feikin, D. R., Russell, J. B. W., Lindblad, R., Kargbo, S. A. S., Samai, M., and Mahon, B. E., “Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola.”, J Infect Dis, vol. 217, no. suppl_1, pp. S33-S39, 2018.
R. Spellecy, Tarima, S., Denzen, E., Moore, H., Abhyankar, S., Dawson, P., Foley, A., Gersten, I., Horwitz, M., Idossa, L., Joffe, S., Kamani, N., King, R., Lazaryan, A., Morris, L., Horowitz, M. M., and Majhail, N. S., “Easy-to-Read Informed Consent Form for Hematopoietic Cell Transplantation Clinical Trials: Results from the Blood and Marrow Transplant Clinical Trials Network 1205 Study.”, Biol Blood Marrow Transplant, vol. 24, no. 10, pp. 2145-2151, 2018.
C. M Berin, Grishin, A., Masilamani, M., Leung, D. Y. M., Sicherer, S. H., Jones, S. M., A Burks, W., Henning, A. K., Dawson, P., Grabowska, J., Agashe, C., Davidson, W. F., Wood, R. A., and Sampson, H. A., “Egg-specific IgE and basophil activation but not egg-specific T-cell counts correlate with phenotypes of clinical egg allergy.”, J Allergy Clin Immunol, vol. 142, no. 1, pp. 149-158.e8, 2018.
A. E. Fombah, Goldstein, S. T., Jarrett, O. D., Jalloh, M. I., El-Khorazaty, J., Lisk, D. Radcliffe, Legardy-Williams, J., Pratt, D. A., George, P. M., Russell, J. B. W., Schrag, S. J., Dawson, P., Deen, G. F., Carr, W., Lindblad, R., James, F., Bah, M. M., Yillia, J. F., Sandy, J. D., Turay, P. E., Conteh, M. - A., Slutsker, L., Mahon, B. E., Samai, M., and Seward, J. F., “Health Conditions in an Adult Population in Sierra Leone: Data Reported From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).”, J Infect Dis, vol. 217, no. suppl_1, pp. S75-S80, 2018.
M. Rao, Onkar, S., Peachman, K. K., White, Y., Trinh, H. V., Jobe, O., Zhou, Y., Dawson, P., Eller, M. A., Matyas, G. R., and Alving, C. R., “Liposome-Encapsulated Human Immunodeficiency Virus-1 gp120 Induces Potent V1V2-Specific Antibodies in Humans.”, J Infect Dis, vol. 218, no. 10, pp. 1541-1550, 2018.
O. D. Jarrett, Seward, J. F., Fombah, A. E., Lindblad, R., Jalloh, M. I., El-Khorazaty, J., Dawson, P., Burton, D., Zucker, J., Carr, W., Bah, M. M., Deen, G. F., George, P. M., James, F., Lisk, D. R., Pratt, D., Russell, J. B. W., Sandy, J. D., Turay, P., Hamel, M. J., Schrag, S. J., Walker, R. E., Samai, M., and Goldstein, S. T., “Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola.”, J Infect Dis, vol. 217, no. suppl_1, pp. S24-S32, 2018.
R. J. Carter, Senesi, R. G. B., Dawson, P., Gassama, I., Kargbo, S. A. S., Petrie, C. R., Rogers, M. Hashim, Samai, M., and Luman, E. T., “Participant Retention in a Randomized Clinical Trial in an Outbreak Setting: Lessons From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).”, J Infect Dis, vol. 217, no. suppl_1, pp. S65-S74, 2018.
M. Chehade, Jones, S. M., Pesek, R. D., A Burks, W., Vickery, B. P., Wood, R. A., Leung, D. Y. M., Furuta, G. T., Fleischer, D. M., Henning, A. K., Dawson, P., Lindblad, R. W., Sicherer, S. H., J Abonia, P., Sherrill, J. D., Sampson, H. A., and Rothenberg, M. E., “Phenotypic Characterization of Eosinophilic Esophagitis in a Large Multicenter Patient Population from the Consortium for Food Allergy Research.”, J Allergy Clin Immunol Pract, vol. 6, no. 5, pp. 1534-1544.e5, 2018.
K. Modjarrad, Lin, L., George, S. L., Stephenson, K. E., Eckels, K. H., De La Barrera, R. A., Jarman, R. G., Sondergaard, E., Tennant, J., Ansel, J. L., Mills, K., Koren, M., Robb, M. L., Barrett, J., Thompson, J., Kosel, A. E., Dawson, P., Hale, A., C Tan, S., Walsh, S. R., Meyer, K. E., Brien, J., Crowell, T. A., Blazevic, A., Mosby, K., Larocca, R. A., Abbink, P., Boyd, M., Bricault, C. A., Seaman, M. S., Basil, A., Walsh, M., Tonwe, V., Hoft, D. F., Thomas, S. J., Barouch, D. H., and Michael, N. L., “Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials.”, Lancet, vol. 391, no. 10120, pp. 563-571, 2018.
C. E. Allen, Marsh, R., Dawson, P., Bollard, C. M., Shenoy, S., Roehrs, P., Hanna, R., Burroughs, L., Kean, L., Talano, J. - A., Schultz, K. R., Pai, S. - Y., K Baker, S., Andolina, J. R., Stenger, E. O., Connelly, J., Ramirez, A., Bryant, C., Eapen, M., and Pulsipher, M. A., “Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies.”, Blood, vol. 132, no. 13, pp. 1438-1451, 2018.
M. Samai, Seward, J. F., Goldstein, S. T., Mahon, B. E., Lisk, D. Radcliffe, Widdowson, M. - A., Jalloh, M. I., Schrag, S. J., Idriss, A., Carter, R. J., Dawson, P., Kargbo, S. A. S., Leigh, B., Bawoh, M., Legardy-Williams, J., Deen, G., Carr, W., Callis, A., Lindblad, R., Russell, J. B. W., Petrie, C. R., Fombah, A. E., Kargbo, B., McDonald, W., Jarrett, O. D., Walker, R. E., Gargiullo, P., Bash-Taqi, D., Gibson, L., Fofanah, A. Bakarr, and Schuchat, A., “The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak.”, J Infect Dis, vol. 217, no. suppl_1, pp. S6-S15, 2018.
D. Chiang, Chen, X., Jones, S. M., Wood, R. A., Sicherer, S. H., A Burks, W., Leung, D. Y. M., Agashe, C., Grishin, A., Dawson, P., Davidson, W. F., Newman, L., Sebra, R., Merad, M., Sampson, H. A., Losic, B., and M Berin, C., “Single-cell profiling of peanut-responsive T cells in patients with peanut allergy reveals heterogeneous effector T2 subsets.”, J Allergy Clin Immunol, vol. 141, no. 6, pp. 2107-2120, 2018.
2017
W. N. Hannah, Hakre, S., Dawson, P., Wu, H., Peel, S. A., Michael, N. L., Scott, P. T., and Okulicz, J. F., “Clinical indicators associated with HIV acquisition in the United States Air Force.”, AIDS Care, vol. 29, no. 6, pp. 724-728, 2017.
S. M. Jones, Sicherer, S. H., A Burks, W., Leung, D. Y. M., Lindblad, R. W., Dawson, P., Henning, A. K., M Berin, C., Chiang, D., Vickery, B. P., Pesek, R. D., Cho, C. B., Davidson, W. F., Plaut, M., Sampson, H. A., and Wood, R. A., “Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults.”, J Allergy Clin Immunol, vol. 139, no. 4, pp. 1242-1252.e9, 2017.
C. Agashe, Chiang, D., Grishin, A., Masilamani, M., Jones, S. M., Wood, R. A., Sicherer, S. H., A Burks, W., Leung, D. Y. M., Dawson, P., Sampson, H. A., and M Berin, C., “Impact of granulocyte contamination on PBMC integrity of shipped blood samples: Implications for multi-center studies monitoring regulatory T cells.”, J Immunol Methods, vol. 449, pp. 23-27, 2017.
J. Ananworanich, Eller, L. Anne, Pinyakorn, S., Kroon, E., Sriplenchan, S., Fletcher, J. Lk, Suttichom, D., Bryant, C., Trichavaroj, R., Dawson, P., Michael, N., Phanuphak, N., and Robb, M. L., “Viral kinetics in untreated versus treated acute HIV infection in prospective cohort studies in Thailand.”, J Int AIDS Soc, vol. 20, no. 1, p. 21652, 2017.
2016
D. M. Brett-Major, Frick, K. D., Malia, J. A., Hakre, S., Okulicz, J. F., Beckett, C. G., Jagodinski, L. L., Forgione, M. A., Gould, P. L., Harrison, S. A., Murray, C. K., Rentas, F. J., Armstrong, A. W., Hayat, A. M., Pacha, L. A., Dawson, P., Eick-Cost, A. A., Maktabi, H. H., Michael, N. L., Cersovsky, S. B., Peel, S. A., and Scott, P. T., “Costs and consequences: Hepatitis C seroprevalence in the military and its impact on potential screening strategies.”, Hepatology, vol. 63, no. 2, pp. 398-407, 2016.
S. Bunyavanich, Shen, N., Grishin, A., Wood, R., Burks, W., Dawson, P., Jones, S. M., Leung, D. Y. M., Sampson, H., Sicherer, S., and Clemente, J. C., “Early-life gut microbiome composition and milk allergy resolution.”, J Allergy Clin Immunol, vol. 138, no. 4, pp. 1122-1130, 2016.